Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
CV
STRONG SELLCapsoVision, Inc. · Healthcare · United States · $324M · Avg Vol: $1M/d
17
StockRankGet insider-trade alerts
Q
31
V
21
M
47
P/E (TTM)
—
ROE
-185.1%
D/E
0.0x
Dividend %
—
COMPANY DESCRIPTION
CapsoVision, Inc. is a medical device company specializing in the development and commercialization of innovative capsule endoscopy systems for gastrointestinal diagnostics. Its proprietary technology offers a non-invasive method for examining the small bowel, aiming to provide superior imaging capabilities and a more comfortable diagnostic experience for patients.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.8M | 11.8M | 13.6M | 17.9% | 13.6M | 15.6M | 21.5M | 25.9% |
| EPS | -0.29 | -0.43 | -1.03 | — | -1.06 | -0.52 | -0.42 | — |
| Shares | 46.3M | 46.3M | 46.9M | +1.1% | 50.0M | — | — | — |
| Debt | 1.5M | 1.2M | 0.9M | -23.5% | 0.8M | — | — | — |
| Equity | -109.8M | -129.5M | 13.3M | — | — | — | — | — |
| Op CF | -10.8M | -20.1M | -22.9M | — | -23.9M | — | — | — |
| Inv CF | -0.8M | -0.2M | -90.0K | — | — | — | — | — |
| Fin CF | 20.5M | 15.1M | 23.6M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-8.1%
SMA 50SMA 200
Close
$6.61
RSI (14)
67.0
52W High
$15.37
From 52W High
0.4%
SCORE BREAKDOWN
Quality
31
ROIC
-185.7%2.8
ROE
-185.1%4.5
GP/Assets
38.6%78.8
Op. Margin
-254.0%13.2
FCF/Assets
-72.9%3.1
Piotroski
316.0
Int. Cover
—N/A
D/E Ratio
0.04x73.3
Current Ratio
4.57x67.9
Value
21
P/E (TTM)
—N/A
EV/EBITDA
-11.9x25.0
P/FCF
—N/A
P/B
16.6x6.8
P/S
24.9x14.8
Div Yield
—N/A
Momentum
47
52W High %
43%18.6
RS 6M
2%75.1
SMA 50/200
1.03x71.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$324M
P/E (Forward)
—
Gross Margin
51.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| CV | CapsoVision, Inc.(you) | $324M | 17 | STRONG SELL |
| CATX | Perspective Therapeutics, Inc. | $332M | 16 | STRONG SELL |
| LAB | Standard BioTools Inc. | $326M | 22 | SELL |
| TLSI | TriSalus Life Sciences, Inc. | $259M | 16 | STRONG SELL |
| SGHT | Sight Sciences, Inc. | $267M | 21 | SELL |
| IMR.AX | Imricor Medical Systems, Inc. | $455M | 15 | STRONG SELL |
| CLPT | ClearPoint Neuro, Inc. | $423M | 13 | STRONG SELL |
| MOBI | Mobia Medical, Inc. | $361M | 7 | STRONG SELL |
| RXST | RxSight, Inc. | $215M | 23 | SELL |
| QTRX | Quanterix Corporation | $173M | 20 | SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%